Skip to main content
. 2014 Dec 10;9(2):987–993. doi: 10.3892/ol.2014.2787

Figure 1.

Figure 1

Median PFS of 79 patients who underwent combined chemotherapy followed by maintenance treatment. PFS, progression-free survival; XD, docetaxel plus capecitabine.